Company has transitioned from a speculative play to a high-growth profitable business. Lead drug Xyosted continues phenomenal growth and promises increasingly profitable operations for the foreseeable ...
CHICAGO--(BUSINESS WIRE)--Antares today announced that it closed more than 220 transactions in 2020, issuing nearly $14 billion in financing commitments to middle market private equity-backed ...
Ladies and gentlemen, welcome to the Antares Pharma Fourth Quarter and Full-Year 2020 Financial and Operating Results Conference Call. Throughout today's recorded presentation, all participants will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback